news Archives - Page 41 of 100 - Journal for Clinical Studies

Current Edition

Europe

Ionis, Akcea succeed in heart drug trial, setting up Novartis decision

Akcea Therapeutics and Ionis Pharmaceuticals rolled out successful Phase 2 study results Wednesday showing their drug candidate lowered Lp(a), short for lipoprotein(a...

15 November 2018 Europe | news | North America

Continue Reading →

Europe

‘Super’-responder analysis gives more power to Viking’s fatty liver drug

Researchers Monday presented more complete results from Viking Therapeutics' 12-week Phase 2 study of VK2809 at The Liver Meeting 2018, after previously announcing in...

15 November 2018 Europe | news | North America

Continue Reading →

news

Sobi snags rights to AstraZeneca drugs in another immunology play

Swedish pharma Sobi has inked a $1.5 billion cash and equity deal to secure rights to two AstraZeneca drugs that it believes will strengthen its position both in the ...

15 November 2018 news | North America

Continue Reading →

news

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturi...

15 November 2018 news | North America

Continue Reading →

news

Novartis announces clinical collaboration with Pfizer to advance the treatment of NASH

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compou...

8 November 2018 news | North America | Regional News

Continue Reading →

Europe

Chronic inflammation linked with increased risk of multiple diseases and shorter lifespan

Researchers have elucidated the disease risk underlying a biomarker predictive of shorter lifespan. Researchers have been able to unravel the disease burden that unde...

8 November 2018 Europe | news | Regional News

Continue Reading →

news

Oral antibiotic shows promise to cure uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multic...

8 November 2018 news | North America | Regional News

Continue Reading →

Europe

Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes

Excellent safety profile reported so far, results expected summer 2019 Liège, Belgium, November 5, 2018 – Imcyse, who develop active specific immunotherapies for the ...

8 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases

Candidate molecules have the potential to treat multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and systemic inflammatory disea...

8 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma

First dose has been administered in the multiple-center study BN-Brachyury for the treatment of chordoma received FDA Orphan Drug Designation in May 2018 COPEN...

8 November 2018 Europe | news | Regional News

Continue Reading →